AmerisourceBergen 2014 Annual Report Download - page 3

Download and view the complete annual report

Please find page 3 of the 2014 AmerisourceBergen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 28

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28

In fiscal 2014, we exceeded all of
our financial objectives. Our revenues
for the full year were up 36%. Our
adjusted earnings per share were up
24%, and we generated free cash flow
of $1.2 billion. We made substantial
investments in our infrastructure,
acquired a minority stake in
Profarma Distribuidora de Produtos
Farmauticos S.A., in Brazil, and also
invested in a specialty joint venture
with Profarma. We successfully
refinanced $500 million of our long-term
debt, and taking both of our share
repurchase programs together we
bought back over $750 million of
our common stock. As a result
of our thoughtful stewardship of the
Companys capital, we enter fiscal 2015
with tremendous financial flexibility.
Our execution was equally as
strong from an operational perspective.
We successfully implemented the largest
and most complex contract in our history,
the distribution of pharmaceuticals to
all Walgreens stores, and did so ahead
of schedule. We opened a new state-of-
the-art pharmaceutical distribution
center in Florida, and expanded and
augmented several other facilities all
while improving service levels to all
of our customers. Furthermore, we
enhanced our relationships with suppliers
through the introduction of new
To Our Stockholders:
Fiscal 2014 was an historic year for AmerisourceBergen, and I could
not be more proud of the way the whole company pulled together
to deliver the stellar financial and operational performance we
achieved together in fiscal 2014. Over the last few years we have
examined our industry with fresh eyes, and we have taken bold
steps to enhance the role of the wholesaler in the marketplace.
The knowledge and expertise we have developed, our partnership
philosophy, and our increasingly global reach enable us to
influence and shape healthcare delivery by providing unique
solutions for both pharmaceutical manufacturers and healthcare
providers. Through innovation and execution, we creatively
address the current challenges in healthcare, and grow
our business by driving value for all
of our stakeholders.
Steven H. Collis,
President and
Chief Executive Officer
1